Citation Impact
Citing Papers
A microRNA expression signature of human solid tumors defines cancer gene targets
2006 Standout
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
2012
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells
2005
TGF-β and cancer
1999
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
1999
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Role of Radiation-induced TGF-beta Signaling in Cancer Therapy
2009
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Cancer to bone: a fatal attraction
2011 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Smad transcription factors
2005 Standout
Overexpression of transforming growth factor ?-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells
1999
Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer
1998
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer
1997
TGF-β signalling from cell membrane to nucleus through SMAD proteins
1997 StandoutNature
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Alteration of cell growth and morphology by overexpression of transforming growth factor β type II receptor in human lung adenocarcinoma cells
2001
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer
2009
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
1997 StandoutNature
Transforming growth factor-β in cancer and metastasis
2006
The unseen majority: soil microbes as drivers of plant diversity and productivity in terrestrial ecosystems
2007 Standout
RhoB, Not RhoA, Represses the Transcription of the Transforming Growth Factor β Type II Receptor by a Mechanism Involving Activator Protein 1
2002
The molecular biology of head and neck cancer
2010 Standout
Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells
1995
Mutations of the transforming growth factor β type II receptor gene and microsatellite instability in gastric cancer
1996
Putting tumours in context
2001 Standout
Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
2000
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
TGF-β receptor signaling
1997
Mammalian Rho GTPases: new insights into their functions from in vivo studies
2008 Standout
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Potent Prostaglandin A1 Analogs That Suppress Tumor Cell Growth through Induction of p21 and Reduction of Cyclin E
1998 StandoutNobel
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
1998 Standout
Binding Affinity of Transforming Growth Factor-β for Its Type II Receptor Is Determined by the C-terminal Region of the Molecule
1996
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Structure of the Ultra-High-Affinity Colicin E2 DNase–Im2 Complex
2012 StandoutNobel
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
TGFβ in Cancer
2008 Standout
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
2008 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Bacteriocin diversity: ecological and evolutionary perspectives
2002
Rho and Rac Take Center Stage
2004 Standout
Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues
1997
The basics of epithelial-mesenchymal transition
2009 Standout
Mechanisms of Bone Metastasis
2004 Standout
Increased tumorigenicity in the human pancreatic cell line MIA PaCa‐2 Is associated with an aberrant regulation of an IGF‐1 autocrine loop and lack of expression of the TGF‐β type RII receptor
1995
How cells read TGF-β signals
2000 Standout
Control of Type II Transforming Growth Factor-β Receptor Expression by Integrin Ligation
1999
Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck
1997
Fibroblasts in cancer
2006 Standout
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Experimental and Computational Analyses of the Energetic Basis for Dual Recognition of Immunity Proteins by Colicin Endonucleases
2008 StandoutNobel
Transforming Growth Factor-β-mediated p15INK4BInduction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines
1999
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
2000 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Analyses of microsatellite instability and the transforming growth factor‐β receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features
1999
Tumor suppressor activity of the TGF-β pathway in human cancers
1996
Blockade of Transforming Growth Factor-β Signaling Does Not Abrogate Antiestrogen-induced Growth Inhibition of Human Breast Carcinoma Cells
1997
Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia
1999
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
1996
The structural and energetic basis for high selectivity in a high-affinity protein-protein interaction
2010 StandoutNobel
Gut Microbiota in Health and Disease
2010 Standout
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.
1995
Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
1999
TGF-β SIGNAL TRANSDUCTION
1998 Standout
Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
1997
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in‐situ and invasive carcinomas
2000
Mice with Enhanced Macrophage Angiotensin-Converting Enzyme Are Resistant to Melanoma
2007 StandoutNobel
Colicin Biology
2007
MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
2001
The latent transforming growth factor β binding protein (LTBP) family
2000
Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
1999
TbetaR-I(6A) is a candidate tumor susceptibility allele.
1999
Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β
1999
Total bacterial diversity in soil and sediment communities—A review
1996
Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.
2002
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins
1997 StandoutNobel
Works of J. Wang being referenced
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
1994
Nucleotide polymorphism in colicin E1 and Ia plasmids from natural isolates of Escherichia coli.
1994